MICHELLE FERNANDEZ: Open Payments
NPI 1730833799 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 111 payments from 20 companies in 2025. Trend: 2023 $3,685 · 2024 $2,655 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $586 |
| Neurocrine BioSciences, Inc. | 5 | $183 |
| ARGENX US, INC. | 8 | $169 |
| PFIZER INC. | 8 | $151 |
| Lundbeck LLC | 8 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| UCB, Inc. | 3 | $95 |
| Biogen, Inc. | 5 | $88 |
| Lilly USA, LLC | 4 | $74 |
| Alexion Pharmaceuticals, Inc. | 3 | $62 |
Products named: UBRELVY, INGREZZA, VYVGART HYTRULO, REXULTI, NURTEC ODT, VYEPTI, BOTOX, QULIPTA.
Industry payments across NV — which companies pay providers there.
